Results 101 to 110 of about 2,733 (199)

Mpox treatment information for healthcare professionals [PDF]

Updated July 10, 2023Patients are still developing severe mpox. A March 3, 2023, MMWR provides updated clinical treatment considerations about using therapeutics to treat severe mpox cases, including ocular infections, neurologic complications ...

core  

Guidance for Tecovirimat use under expanded access investigational new drug protocol during 2022 U.S. monkeypox cases [PDF]

Updated August 3, 2022Tecovirimat (also known as TPOXX or ST-246) is FDA-approved for the treatment of human smallpox disease caused by Variola virus in adults and children. However, its use for other orthopoxvirus infections, including monkeypox, is not

core  

“If that would have lessened my symptoms, that would have been great...”: a qualitative study about the acceptability of tecovirimat as treatment for mpox

BMC Medicine
Background Tecovirimat, an antiviral treatment for smallpox, was approved as a treatment for mpox by the European Medicines Agency in January 2022.
Sara Paparini, Rosalie Hayes, Benjamin Weil, Will Nutland, Ismael Maatouk, Teodora Wi, Chloe M. Orkin, Rosamund Lewis   +7 more
doaj   +1 more source

Monkeypox outbreak : updates on the epidemiology, testing, treatment, and vaccination [PDF]

This COCA Call will provide updates on the epidemiology of the monkeypox outbreak, commercial testing capability, how to obtain and use TPOXX (tecovirimat) to treat monkeypox, and vaccine strategy ...

core  

Tecovirimat [PDF]

, 2020
openaire   +1 more source

Clinical considerations for treatment and prophylaxis of mpox infection in people who are immunocompromised [PDF]

Updated June 26, 2023Mpox in People Who are Immunocompromised -- Diagnosis -- Treatment ...

core  

La curcumina y sus derivados como posibles candidatos antivirales contra la viruela del mono (mpox): una revisión de estudios computacionales [PDF]

Introduction: Monkeypox (mpox) is an infectious disease caused by the mpox virus that is of global health concern because the outbreak, as of May 2023, has affected more than 80,000 people in hundreds of countries.
Al Atsariyah, Hamnah, Nur'aini, Anisa Dias, Nurhuda, Andang, Ridho, Fiki Muhammad, Syachputra, Andika Julyanto, Wardana, Wisnu Eka   +5 more
core   +1 more source

Mechanisms of Tecovirimat Antiviral Activity and Poxvirus Resistance

Abstract Mpox is a zoonotic disease endemic in central and west Africa. However, since 2022, human-adapted mpox virus (MPXV) strains are causing large outbreaks spreading outside these regions, leading the World Health Organization to declare public health emergency twice. Tecovirimat, the most widely used drug to treat these infections, blocks
Vernuccio, Riccardo, Martínez León, Alejandro, Poojari, Chetan, Buchrieser, Julian, Selverian, Christopher, Jaleta, Yakin, Meola, Annalisa, Guivel-Benhassine, Florence, Porrot, Françoise, Haouz, Ahmed, Chevreuil, Maelen, Raynal, Bertrand, Mercer, Jason, Simon-Loriere, Etienne, Chandran, Karti, Schwartz, Olivier, Hub, Jochen S., Guardado-Calvo, Pablo   +17 more
openaire   +2 more sources

Update for clinicians on testing and treatment for monkeypox [PDF]

Distributed via the CDC Health Alert NetworkJuly 28, 2022, 9:00 PM ETCDCHAN-00471As of July 28, 2022, the Centers for Disease Control and Prevention (CDC) and state and local public health partners are reporting 4,907 cases of monkeypox in the United ...

core  

Treatment of Severe Ocular Mpox with Cidofovir and Tecovirimat. [PDF]

Emerg Infect Dis
Brousse X, Kreidie R, Mourgues E, Fraysse L, Lahouati M, Servant V, Burrel S, Saunier V, Cazanave C.   +8 more
europepmc   +1 more source